SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Thoracic Oncology Consultation — Jesse Owens

PatientJesse Owens
Date of birth1960-09-12
IdentifiersMRN HR-ML042-SYN; SSN (made up) 000-42-8319
Document date2026-05-26
AuthorNgozi Halvorsen-Pierce, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Lung-RADS 4X nodule on a first low-dose screening CT in a 65-year-old man who smokes a pack a day (35 pack-years): a solid, spiculated 2.9 cm left upper lobe nodule with an enlarged 1.6 cm left hilar node. PET-CT and brain MRI are booked this week and EBUS staging after that. Please see him within two weeks to review the results with him and plan treatment if this is cancer. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Mr. Owens, 65, is seen at the request of Dr. Whitfield-Arroyo 15 days after his first low-dose screening CT showed a Lung-RADS 4X left upper lobe nodule and an enlarged left hilar node. Since then he has had PET-CT, brain MRI, endobronchial ultrasound with node sampling, and pulmonary function tests this morning, and our thoracic tumor board reviewed him five days ago. He has a long-standing morning cough and no other symptoms. He smokes a pack a day, 35 pack-years, and says he is ready to stop. He is fully active (ECOG 0). [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days (starting week), with a quit date on day 80.5 mg daily on days 1 to 3, then 0.5 mg twice daily on days 4 to 7Oral route2026-05-26 to 2026-06-01completedS
Folic acid 1 mg oral tablet, one tablet daily from one week before the first pemetrexed dose until three weeks after the lastOne tablet dailyOral route2026-05-26 to 2026-08-05completedS
Cyanocobalamin (vitamin B12) 1000 mcg intramuscular injection, one dose a week before the first pemetrexed dose (repeat every nine weeks while on pemetrexed)1000 mcg once; a second dose was not due before pemetrexed endedIntramuscular route2026-05-26 to 2026-05-26completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Solid, spiculated 2.9 cm nodule in the left upper lobe with an enlarged (1.6 cm) left hilar lymph node on today's low-dose screening CT, Lung-RADS 4X (very suspicious); no symptoms of lung cancer. PET-CT, tissue diagnosis and thoracic oncology review bookedresolvedconfirmed R91.1S — Synthetic presenting screening finding in a long-term smoker. Superseded by the diagnosis at the second visit.
Adenocarcinoma of the left upper lobe of the lung, cT1c N1 M0, stage IIB (AJCC 8th edition), resectable: 2.9 cm primary with a positive left interlobar (11L) node on EBUS; mediastinal nodes 4R, 4L and 7 negative; no metastases on PET-CT or brain MRI. PD-L1 tumor proportion score 40 percent (22C3); KRAS G12C mutation; no EGFR, ALK, ROS1, BRAF, MET exon 14, RET, NTRK or HER2 alterationactiveconfirmed C34.12S — Synthetic histology, stage and biomarkers linked to his documented adenocarcinoma of the left lung; in the modern episode it is found by screening while still resectable.
Nicotine dependence, cigarettes: a pack a day for 35 years (35 pack-years); smokes his first cigarette within 30 minutes of waking; two attempts to stop, each lasting a few weeks without medicineactiveconfirmed F17.210S — Synthetic modern entry linked to his documented smoking; superseded at the visit after surgery by nicotine dependence in early remission.

Physical Exam

Vital signs recorded on 2026-05-26; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell and upright; weight 76.6 kg; blood pressure 130/80, pulse 80; oxygen saturation 95 percent; ECOG 0
Lymph nodesNo supraclavicular or cervical nodes
RespiratoryScattered rhonchi that clear with a cough; no wheeze
ExtremitiesNo clubbing

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-26Hemoglobin [Mass/volume] in Blood14.9g/dL13.5-17.5 g/dLNormalS
2026-05-26Leukocytes [#/volume] in Blood by Automated count8.110*3/uL4-11 10*3/uLNormalS
2026-05-26Neutrophils [#/volume] in Blood by Automated count5.210*3/uL1.5-7.7 10*3/uLNormalS
2026-05-26Platelets [#/volume] in Blood by Automated count25810*3/uL150-400 10*3/uLNormalS
2026-05-26Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.7-1.3 mg/dLNormalS
2026-05-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M84mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-26Glucose [Mass/volume] in Serum or Plasma97mg/dL70-99 mg/dLNormalS
2026-05-26Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma23U/L7-55 U/LNormalS
2026-05-26Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L8-48 U/LNormalS
2026-05-26Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-05-26Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4 mIU/LNormalS
2026-05-26Thyroxine (T4) free [Mass/volume] in Serum or Plasma1.2ng/dL0.8-1.8 ng/dLNormalS
2026-05-26Cortisol [Mass/volume] in Serum or Plasma13.8ug/dLMorning (8 a.m.) reference intervalNormalS
2026-05-26FEV12.71LLower limit of normal for his age and height (GLI 2012)NormalS
2026-05-26FEV1 measured/predicted86%>=80%NormalS
2026-05-26FEV1/FVC0.73{ratio}Below 0.70 after bronchodilator indicates airflow obstructionNormalS
2026-05-26Diffusion capacity.carbon monoxide23.6mL/min/mm[Hg]Lower limit of normal for his age and height; predicted 27.4NormalS
2026-05-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-05-26Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Assessment

Data reviewed: Dr. Whitfield-Arroyo's intake note and results. Screening CT: 2.9 cm solid spiculated nodule in the apicoposterior left upper lobe; 1.6 cm left hilar node; mild upper-lobe emphysema; coronary calcification. FDG PET-CT: avid nodule (SUVmax 9.8) and avid 11L node (SUVmax 6.1); no mediastinal, supraclavicular or distant uptake. Brain MRI: no metastases. EBUS with systematic sampling: adenocarcinoma in 11L, TTF-1 positive; 4R, 4L, 7 and 10L negative with adequate lymphocytes. PD-L1 (22C3) 40 percent. Tissue sequencing with concordant plasma testing: KRAS G12C; STK11 and KEAP1 wild type; no EGFR, ALK, ROS1, BRAF V600E, MET exon 14, RET, NTRK or HER2 alteration. Pulmonary function today: FEV1 2.71 L (86 percent predicted), FEV1/FVC 0.73, DLCO 86 percent predicted. Today's blood count, creatinine 1.0 mg/dL, liver tests, TSH 1.9 and morning cortisol 13.8 are normal. [S]

Plan of Treatment